Additional information DISCLOSURE/CONFLICT OF INTEREST Michael Berk declares that over the past three years, he has received compensation from Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Norvatis, Mayne Pharma and Servier
S5 Effect of dopamine-coupled non-targeted (3-PLG-dopa) and alanine-glutathione-targeted (3-PLG-dopa-A-GSH) nanocarriers on the viability of human brain endothelial cells
It may reduce: Glutathione helps flush toxins from the liver, improving overall skin health
Think med spas over day spas, and an intentional pivot among medical professionals to true, preventive care